FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097265 [Registered on: 12/11/2025] Trial Registered Prospectively
Last Modified On: 11/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   A Comparison between the Effect of Ksheerbala Taila and Shatapushpa Taila Matrabasti in Managing Primary Dysmenorrhea 
Scientific Title of Study   Evaluation of comparative efficacy of Ksheerbala Taila Matrabasti versus Shatapushpa Taila Matrabasti in the management of Udavartani Yonivyapad [Primary Dysmenorrhea] 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Janhvi Pawar  
Designation  PG Scholar  
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  Room Number 09 Department Of Prasuti Tantra and Stree Roga Mahatma Gandhi Ayurved College Hospital And Research Centre Hirapur Salod Wardha Maharashtra

Wardha
MAHARASHTRA
442001
India 
Phone  9284259679  
Fax    
Email  Pawarjanhvi655@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Sonal Gajbe Raut  
Designation  Professor And HOD 
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  Room Number 09 Department Of Prasuti Tantra and Stree Roga Mahatma Gandhi Ayurved College Hospital And Research Centre Hirapur Salod Wardha Maharashtra


MAHARASHTRA
442001
India 
Phone  9284259679  
Fax    
Email  Sohum567@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Janhvi Pawar  
Designation  PG Scholar  
Affiliation  Datta Meghe Institute Of Higher Education And Research 
Address  Room Number 09 Department Of Prasuti Tantra and Stree Roga Mahatma Gandhi Ayurved College Hospital And Research Centre Hirapur Salod Wardha Maharashtra


MAHARASHTRA
442001
India 
Phone  9284259679  
Fax    
Email  Pawarjanhvi655@gmail.com  
 
Source of Monetary or Material Support  
MAHATMA GANDHI AYURVED COLLEGE HOSPITAL AND RESEARCH CENTRE HIRAPUR SALOD WARDHA 442001 MAHARASHTRA INDIA  
 
Primary Sponsor  
Name  Janhvi Pawar 
Address  Room Number 09 Department Of Prasuti Tantra and Stree Roga Mahatma Gandhi Ayurved College Hospital And Research Centre Hirapur Salod Wardha 442001 Maharashtra India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Janhvi Pawar  Mahatma gandhi ayurved college hospital and research centre hirapur salod  Department of Prasutitantra and Streerog Mahatma Gandhi Ayurved College Hospital and Research Centre , Salod, Wardha Wardha MAHARASHTRA
Wardha
MAHARASHTRA 
9284259679

pawarjanhvi655@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTINAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N944||Primary dysmenorrhea. Ayurveda Condition: YONIROGAH/YONI-VYAPADAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: samhita, Procedure details: 7 days after mensus for 2 consecutive cycle )
(1) Medicine Name: Shatpushpa Tail, Reference: Bhaishjya Ratnavali, Route: Rectal, Dosage Form: Taila, Dose: 30(ml), Frequency: od, Duration: 7 Days
2Intervention ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: bhaishjya ratnvali, Procedure details: 7 days after menses for two consecutive cycle )
(1) Medicine Name: Ksheerbala tail, Reference: Bhaishjya ratnvali, Route: Rectal, Dosage Form: Taila, Dose: 30(ml), Frequency: od, Duration: 7 Days
 
Inclusion Criteria  
Age From  19.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Patients willing to give written informed consent.Female participants age: 19 to 40 years.Already diagnosed with primary dysmenorrhea (Udavarta Yoni Vyapad). Regular menstrual cycles (21–35 days).  
 
ExclusionCriteria 
Details  Patient having any major or minor systemic disease.
History of secondary Dysmenorrhea due to underlying pathology (e.g., endometriosis,
fibroids) 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvement in clinical parameter of Udavarta Yonivyapad after 4 weeks of completion of trial  Improvement in clinical parameter of Udavarta Yonivyapad after 4 weeks of completion of trial 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   28/11/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

The study compares the effectiveness of Ksheerbala Taila Matrabasti and Shatapushpa Taila Matrabasti in treating Udavartani Yonivyapad or primary dysmenorrhea. It aims to evaluate pain relief and Vata balance through randomized clinical trials establishing a safe evidence-based Ayurvedic treatment for menstrual pain and improved women’s health.

 
Close